<p>周三早晨，随着最新消息传出 <strong>唐纳德·特朗普</strong> 总统即将签署行政命令，将大麻从 第一类药物重新分类为第三类药物。</p>
<ul>
<li><em>CGC 股票正在上涨。</em> 查看此处的图表和价格走势。</li>
</ul>
<p>这一消息在大麻行业引发了一波乐观情绪，投资者期待与第三类药物相关的长期财务解放：即取消国税局第 280E 条款。</p>
<p><strong>接下来阅读：</strong> 埃隆·马斯克准备进行 SpaceX IPO，估值超过 RTX、波音和洛克希德的总和</p>
<h2>税收减免</h2>
<p>税法第 280E 条款 禁止 企业从与第一类或第二类物质的贩运相关的收入中扣除其他已确立的商业费用。</p>
<p>多年来，280E 条款使美国的大麻经营者陷入困境，阻止他们扣除标准商业费用，导致有效税率往往超过 70%。</p>
<p>将大麻重新分类为较低的分类，例如第三类药物，将解除 280E 的负担，可能使许多大麻企业首次实现盈利。</p>
<p>“这绝对是一个游戏规则的改变，”<strong>博里斯·乔丹</strong>，<strong>Curaleaf Holdings</strong> 的执行董事长，在 2024 年告诉《华尔街日报》。</p>
<p>“这是我们等待了近 10 年的事情，” 乔丹补充道。</p>
<p>然而，专家警告称，第三类药物并不等于完全合法化。</p>
<p>尽管这一举措将缓解研究限制和税收负担，但并不会自动消除联邦对娱乐用途的刑事处罚。</p>
<p>事实上，大麻在联邦法律下仍然是非法的，并且与许多已合法化大麻的州法律之间的冲突仍然存在。</p>
<h2>市场反应</h2>
<p>大麻股票在高于平均水平的交易量下波动，并在社交媒体上引发热议，投资者在等待特朗普总统的正式声明。</p>
<p>投资者可以通过 AdvisorShares Pure US Cannabis ETF (NYSE: MSOS) 以及加拿大重量级公司的个股，如 <strong>Tilray Brands, Inc.</strong> (NASDAQ: TLRY)、<strong>Canopy Growth Corp.</strong> (NASDAQ: CGC)、<strong>Aurora Cannabis Inc.</strong> (NASDAQ: ACB)、<strong>Cronos Group, Inc.</strong> (NASDAQ: CRON) 和 <strong>SNDL Inc.</strong> (NASDAQ: SNDL) 来监控该行业。</p>
<p><strong>接下来阅读：</strong></p>
<ul>
<li>大资金押注特斯拉股票：亿万富翁的牛市与熊市在第三季度</li>
</ul>
<p><em>照片来源：Shutterstock</em></p>

极光大麻

TLRY

SNDL

CRON

<p>大麻股票上涨，因为有报道称特朗普总统可能将大麻重新分类为第三类药物，这可能会减轻国税局第 280E 条款的负担。这一变化可能允许大麻企业扣除标准费用并实现盈利。然而，第三类药物并不意味着完全合法，联邦刑事处罚仍将存在。投资者正密切关注该行业，Tilray、Canopy Growth、Aurora Cannabis、Cronos Group 和 SNDL 等股票的交易活动有所增加</p>

<p>Cannabis stocks rallied Wednesday morning following fresh reports that President <strong>Donald Trump</strong> is poised to sign an executive order rescheduling marijuana from Schedule I to Schedule III.</p>
<div class="lb-trans"><p>周三早晨，随着最新消息传出 <strong>唐纳德·特朗普</strong> 总统即将签署行政命令，将大麻从 第一类药物重新分类为第三类药物。</p>
</div><ul>
<li><em>CGC stock is climbing.</em> See the chart and price action here.</li>
</ul>
<div class="lb-trans"><ul>
<li><em>CGC 股票正在上涨。</em> 查看此处的图表和价格走势。</li>
</ul>
</div><p>The news sent a wave of optimism through the cannabis sector as investors anticipated long-awaited financial liberation associated with Schedule III: the removal of IRS Section 280E.</p>
<div class="lb-trans"><p>这一消息在大麻行业引发了一波乐观情绪，投资者期待与第三类药物相关的长期财务解放：即取消国税局第 280E 条款。</p>
</div><p><strong>Read Next:</strong> Elon Musk Prepares SpaceX IPO Valued At More Than RTX, Boeing, Lockheed Combined</p>
<div class="lb-trans"><p><strong>接下来阅读：</strong> 埃隆·马斯克准备进行 SpaceX IPO，估值超过 RTX、波音和洛克希德的总和</p>
</div><h2>Tax Relief</h2>
<div class="lb-trans"><h2>税收减免</h2>
</div><p>Section 280E of the tax code prohibits businesses from deducting otherwise established business expenses from income associated with the trafficking of Schedule I or II substances.</p>
<div class="lb-trans"><p>税法第 280E 条款 禁止 企业从与第一类或第二类物质的贩运相关的收入中扣除其他已确立的商业费用。</p>
</div><p>For years, 280E has crippled U.S. cannabis operators by preventing them from deducting standard business expenses, resulting in effective tax rates often exceeding 70%.</p>
<div class="lb-trans"><p>多年来，280E 条款使美国的大麻经营者陷入困境，阻止他们扣除标准商业费用，导致有效税率往往超过 70%。</p>
</div><p>Rescheduling cannabis to a lower classification, such as Schedule III, would lift the 280E burden, potentially allowing many cannabis businesses to become profitable for the first time.</p>
<div class="lb-trans"><p>将大麻重新分类为较低的分类，例如第三类药物，将解除 280E 的负担，可能使许多大麻企业首次实现盈利。</p>
</div><p>&#34;It's an absolute game-changer,&#34; <strong>Boris Jordan</strong>, executive chairman of <strong>Curaleaf Holdings</strong>, told the Wall Street Journal in 2024.</p>
<div class="lb-trans"><p>“这绝对是一个游戏规则的改变，”<strong>博里斯·乔丹</strong>，<strong>Curaleaf Holdings</strong> 的执行董事长，在 2024 年告诉《华尔街日报》。</p>
</div><p>&#34;It's something we've been waiting for, for the better part of 10 years,&#34; Jordan added.</p>
<div class="lb-trans"><p>“这是我们等待了近 10 年的事情，” 乔丹补充道。</p>
</div><p>However, experts caution that Schedule III is not full legalization.</p>
<div class="lb-trans"><p>然而，专家警告称，第三类药物并不等于完全合法化。</p>
</div><p>Though the move would ease research restrictions and tax burdens, it does not automatically erase federal criminal penalties for recreational use.</p>
<div class="lb-trans"><p>尽管这一举措将缓解研究限制和税收负担，但并不会自动消除联邦对娱乐用途的刑事处罚。</p>
</div><p>In fact, marijuana would still remain illegal under federal law, and the conflict with many state laws that have legalized cannabis will still exist.</p>
<div class="lb-trans"><p>事实上，大麻在联邦法律下仍然是非法的，并且与许多已合法化大麻的州法律之间的冲突仍然存在。</p>
</div><h2>Market Reaction</h2>
<div class="lb-trans"><h2>市场反应</h2>
</div><p>Cannabis stocks were moving on above-average trading volumes and trending across social media as investors awaited an official statement from President Trump.</p>
<div class="lb-trans"><p>大麻股票在高于平均水平的交易量下波动，并在社交媒体上引发热议，投资者在等待特朗普总统的正式声明。</p>
</div><p>Investors can monitor the sector through the AdvisorShares Pure US Cannabis ETF (NYSE: MSOS) and the individual stocks of Canadian heavyweights like <strong>Tilray Brands, Inc.</strong> (NASDAQ: TLRY), <strong>Canopy Growth Corp.</strong> (NASDAQ: CGC), <strong>Aurora Cannabis Inc.</strong> (NASDAQ: ACB), <strong>Cronos Group, Inc,</strong> (NASDAQ: CRON), and <strong>SNDL Inc.</strong> (NASDAQ: SNDL).</p>
<div class="lb-trans"><p>投资者可以通过 AdvisorShares Pure US Cannabis ETF (NYSE: MSOS) 以及加拿大重量级公司的个股，如 <strong>Tilray Brands, Inc.</strong> (NASDAQ: TLRY)、<strong>Canopy Growth Corp.</strong> (NASDAQ: CGC)、<strong>Aurora Cannabis Inc.</strong> (NASDAQ: ACB)、<strong>Cronos Group, Inc.</strong> (NASDAQ: CRON) 和 <strong>SNDL Inc.</strong> (NASDAQ: SNDL) 来监控该行业。</p>
</div><p><strong>Read Next:</strong></p>
<div class="lb-trans"><p><strong>接下来阅读：</strong></p>
</div><ul>
<li>Big Money Bets On Tesla Stock: Billionaire Bulls and Bears In Q3</li>
</ul>
<div class="lb-trans"><ul>
<li>大资金押注特斯拉股票：亿万富翁的牛市与熊市在第三季度</li>
</ul>
</div><p><em>Photo: Shutterstock</em></p>
<div class="lb-trans"><p><em>照片来源：Shutterstock</em></p>
</div>

高期望：随着特朗普考虑重新调整，大麻股票炙手可热